(Nashua, NH) – Imaging agents that can work at the cellular level are positioned to propel noninvasive diagnostics into a new era. These molecular imaging agents can associate with highly specific markers on the surface of cells to provide unparalleled specificity, creating new opportunities for visualization, targeted drug delivery, and mapping physiological changes over time.
Get the full story...
The early stages of coronary artery disease in young smokers can be reversed quickly if they choose to put out their cigarettes for good, according to a positron emission tomography (PET) imaging study in the December Journal of Nuclear Medicine.
Read the full story
